MORGAN STANLEY

Position in CGON — CG Oncology, Inc.

CIK 895421 NEW YORK, NY

Position in CGON

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$35,208,012

+$12,578,827 QoQ

Shares Held

520,213

-4.6% QoQ

Ownership

0.590%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 64.3709403648121.ToString("F0")% Shared 0.ToString("F0")% None 35.62905963518789.ToString("F0")%

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,423,671,747 across 511 Biotechnology names. CGON ranks #65 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$35,208,012	520,213	-4.6%	Shares	Defined	2026-05-15
2025-12-31	$22,629,185	545,019	-15.2%	Shares	Defined	2026-05-27
2025-09-30	$25,876,433	642,414	-65.6%	Shares	Defined	2026-05-27
2025-06-30	$48,571,848	1,868,148	+97.7%	Shares	Defined	2025-08-15
2025-03-31	$23,145,030	945,081	+30.3%	Shares	Defined	2025-05-15
2024-12-31	$20,799,507	725,227	+208.8%	Shares	Defined	2025-05-15
2024-09-30	$8,861,680	234,871	+148.0%	Shares	Defined	2025-05-14
2024-06-30	$2,989,959	94,709	+28.5%	Shares	Defined	2025-05-14
2024-03-31	$3,236,481	73,724	—	Shares	Defined	2024-10-17
No filing history on record for this holder in this stock.